摘要
目的 观察临床应用匹多莫德口服液治疗小儿支气管哮喘的效果及对机体免疫功能的影响.方法 选取2010年2月~2012年6月我院收治的138例支气管哮喘患儿,按随机数字表法随机分为对照组和观察组各69例,对照组患儿进行常规治疗,观察组患儿常规治疗联合匹多莫德口服液口服,观察两组患者的临床疗效及免疫功能改变.结果 用药后观察组患儿的治疗总有效率较对照组明显升高（P〈0.05）;患儿的抗体水平提高幅度明显高于对照组（P〈0.05）.结论 临床应用匹多莫德口服液治疗小儿支气管哮喘可明显提高机体抗体水平,临床疗效显著.
Objective To observe the clinical application of pidotimod in the treatment of children with bronchial asthma and its effect on immune function. Methods 138 children with bronchial asthma were randomly divided into the control group and the observation group. The control group was given conventional treatment, and the observation group was given conventional therapy combined with pidotimod. The change of clinical and immune function was observed. Results After the treatment, the total effective rate was significantly higher in the observation group than in the control group （P〈0.05）. The level of antibody improved significantly higher in the observation group than in the control group （P〈0.05）. Conclusion The clinical application of pidotimod can obviously improve antibody level and curative effect in the treatment of children with bronchial.
出处
《临床肺科杂志》
2014年第4期619-621,共3页
Journal of Clinical Pulmonary Medicine
关键词
匹多莫德
小儿支气管哮喘
免疫功能
pidotimod
children with bronchial asthma
immune function
